Merck

The Merck Veterinary Manual (MVM) covers all domestic species and diseases in veterinary medicine worldwide. This completely revised and redesigned new edition of the veterinary classic uses a two-col

Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970s through the early 1990s, addresses these issues here. Success with targeted research started Merck on a path that would lead to a series of block-buster therapies that carried the firm to the top of the global industry in the 1990s and Vagelos into the top position at the company. Trained as a physician and scientist, he had to learn how to run a successful business while holding to the highest principles of ethical behavior. He was not always successful. He and his co-author explain where and why he failed to achieve his goals and carefully analyze where he succeeded.

From one of the most trusted names in medical references comes an accessible, all-inclusive guide for older adults that shares what measures to take to optimize the aging process, prevent disease, and

Back by popular demand! The world's most widely used medical reference is now in its 20th edition. The Merck Manual of Diagnosis and Therapy now in its 20th edition has been thoroughly updated and tho

The Merck/Merial Manual for Pet Health delivers animal health expertise in everyday language that all pet owners can understand. This in-depth new resource, authored by over 200 veterinary experts, c

An easy-to-use guide to children’s health from the world’s most widely used medical reference series, revised and updated.The legendary Merck Manual was first published in 1899, and has always been th

"A VALUABLE RESOURCE FOR ANYONE WHO SEEKS A HEALTHIER OLD AGE FOR THEMSELVES OR THEIR LOVED ONES.”–William D. Novelli, CEO, AARPIf aging were an open book, it would be The Merck Manual of Health &

For more than 100 years doctors have been coming to us for advice. Now you can, too.The Merck Manual has traditionally provided exclusive, up-to-the-minute information to doctors, nurses, and other h

The Merck Manual Go-To Home Guide for Symptoms takes complex medical information and makes it easy to understand and accessible to an everyday audience. It covers a wide range of everyday symptoms, f

The Merck Index is the definitive reference work for scientists and professionals looking for authoritative information on chemicals, drugs and biologicals. It has been the leading source of information on chemical compounds for generations of scientists and professionals, selling over one million copies since its publication in 1889.The Merck Index contains over 10,000 monographs with information relating to compounds of significance in research, commerce and environmental impact. The 15th edition, available from RSC Publishing for the first time, is fully revised and updated and contains over 500 new monographs. Over 35% of the existing entries have been updated since the last edition, molecular weights have been recalculated with the latest IUPAC standards and there are revised periodic table and atomic weight tables.The Merck Index now comes with FREE personal one-year access to the The Merck Index Online – a fully searchable database of over 11,500 monographs, including historic m

The Merck/Merial Manual for Pet Health delivers animal health expertise in everyday language that all pet owners can understand. This in-depth new resource, authored by over 200 veterinary experts, c

An in-depth look at big pharma's flagship companyThe Merck Druggernaut takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec.

In Medicine, Science, and Merck, the authors trace the careers of a son of Greek immigrants as he mastered three professions and ultimately became the Chief Executive Officer of America's most admired corporation - the multinational, pharmaceutical giant, Merck and Co., Inc. As the authors show, there was hope even for a wise-cracking kid living through the hard times of the 1930s. Education brought out the scholar in Roy Vagelos, who left his family's small restaurant to attend the University of Pennsylvania, Columbia's Medical School, and Massachusetts General Hospital in Boston. At NIH, he mastered biochemistry; at Washington University he became a distinguished science administrator; and at Merck, he headed the pharmaceutical industry's most innovative laboratory and then became its CEO. Throughout, he never lost touch with his family values, his intense desire to help others, or his faith in the partnership principle and the competition that makes it work.

Networks of Innovation offers an historical perspective on the manner in which private-sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp and Dohme, which acquired Mulford in 1929, and upon Merck & Co Inc., which merged with Sharp and Dohme in 1953. By surveying a century of innovation in biologicals, the authors are able to analyze the conditions that either promoted or prevented creative changes in this important industry. They show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad. This is the first such history to draw exclusively on sources internal to Merck, one of the world's leading innovators in modern vaccines and pharmaceuticals.